DDrare
Disease
Drug
Target Gene/Pathway
Contact
JA
Target Gene/Pathway
Pathway
/
Gene
Search
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Other
Search results
10
50
100
ALL
entries per page:
Showing 1 to 10 of 117 entries
Filter by
Reset
|
No.
KEGG GENES
KEGG PATHWAY
KEGG DRUG
DrugBank
Disease ID
1
BRAF
💬
1. BRAF
×
Name
Full Name
BRAF
B-Raf proto-oncogene, serine/threonine kinase
[44]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB signaling pathway
,
Rap1 signaling pathway
,
cAMP signaling pathway
,
Chemokine signaling pathway
,
FoxO signaling pathway
,
mTOR signaling pathway
,
Vascular smooth muscle contraction
,
Focal adhesion
,
Natural killer cell mediated cytotoxicity
,
Long-term potentiation
,
Neurotrophin signaling pathway
,
Serotonergic synapse
,
Long-term depression
,
Regulation of actin cytoskeleton
,
Insulin signaling pathway
,
Progesterone-mediated oocyte maturation
,
Parathyroid hormone synthesis, secretion and action
,
Cushing syndrome
,
Alzheimer disease
,
Pathways of neurodegeneration - multiple diseases
,
Alcoholism
,
Hepatitis C
,
Hepatitis B
,
Pathways in cancer
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
Colorectal cancer
,
Renal cell carcinoma
,
Pancreatic cancer
,
Endometrial cancer
,
Glioma
,
Prostate cancer
,
Thyroid cancer
,
Melanoma
,
Bladder cancer
,
Chronic myeloid leukemia
,
Acute myeloid leukemia
,
Non-small cell lung cancer
,
Breast cancer
,
Hepatocellular carcinoma
,
Gastric cancer
[44]
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB s
...
Sorafenib
Sorafenib
💬
1. BRAF
×
Name
Other Names
Sorafenib
Sorafenib (USAN/INN)
Sorafenib
[2]
34
34
,
86
💬
1. BRAF
×
Disease ID
Name
34
Neurofibromatosis
86
Pulmonary arterial hypertension
2
BRAF
💬
2. BRAF
×
Name
Full Name
BRAF
B-Raf proto-oncogene, serine/threonine kinase
[44]
EGFR tyrosine kinase inhibitor resistance
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB signaling pathway
,
Rap1 signaling pathway
,
cAMP signaling pathway
,
Chemokine signaling pathway
,
FoxO signaling pathway
,
mTOR signaling pathway
,
Vascular smooth muscle contraction
,
Focal adhesion
,
Natural killer cell mediated cytotoxicity
,
Long-term potentiation
,
Neurotrophin signaling pathway
,
Serotonergic synapse
,
Long-term depression
,
Regulation of actin cytoskeleton
,
Insulin signaling pathway
,
Progesterone-mediated oocyte maturation
,
Parathyroid hormone synthesis, secretion and action
,
Cushing syndrome
,
Alzheimer disease
,
Pathways of neurodegeneration - multiple diseases
,
Alcoholism
,
Hepatitis C
,
Hepatitis B
,
Pathways in cancer
,
Proteoglycans in cancer
,
Chemical carcinogenesis - reactive oxygen species
,
Colorectal cancer
,
Renal cell carcinoma
,
Pancreatic cancer
,
Endometrial cancer
,
Glioma
,
Prostate cancer
,
Thyroid cancer
,
Melanoma
,
Bladder cancer
,
Chronic myeloid leukemia
,
Acute myeloid leukemia
,
Non-small cell lung cancer
,
Breast cancer
,
Hepatocellular carcinoma
,
Gastric cancer
[44]
EGFR tyrosine kinase inhibitor resistance
,
Endocrine resistance
,
MAPK signaling pathway
,
ErbB s
...
Dabrafenib
Dabrafenib
💬
2. BRAF
×
Name
Other Names
Dabrafenib
Dabrafenib (USAN)
Dabrafenib
[1]
34
34
💬
2. BRAF
×
Disease ID
Name
34
Neurofibromatosis
3
C5
💬
3. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Eculizumab
Eculizumab
💬
3. C5
×
Name
Other Names
Eculizumab
Eculizumab (USAN/INN)
Eculizumab (genetical recombination) (JAN)
Soliris (TN)
Eculizumab
[7]
11
11
,
13
,
14
,
61
,
62
,
109
,
222
💬
3. C5
×
Disease ID
Name
11
Myasthenia gravis
13
Multiple sclerosis/Neuromyelitis optica
14
Chronic inflammatory demyelinating polyneuropathy
61
Autoimmune hemolytic anemia
62
Paroxysmal nocturnal hemoglobinuria
109
Atypical hemolytic uremic syndrome
222
Primary nephrotic syndrome
4
C5
💬
4. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Ravulizumab
Ravulizumab
💬
4. C5
×
Name
Other Names
Ravulizumab
Ravulizumab (USAN)
Ravulizumab (genetical recombination) (JAN)
Ultomiris (TN)
Ravulizumab
[7]
2
2
,
11
,
13
,
50
,
62
,
66
,
109
💬
4. C5
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
11
Myasthenia gravis
13
Multiple sclerosis/Neuromyelitis optica
50
Dermatomyositis
62
Paroxysmal nocturnal hemoglobinuria
66
IgA nephropathy
109
Atypical hemolytic uremic syndrome
5
C5
💬
5. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Vilobelimab
Vilobelimab
💬
5. C5
×
Name
Other Names
Vilobelimab
Vilobelimab (USAN)
Vilobelimab
[3]
43
43
,
44
,
269
💬
5. C5
×
Disease ID
Name
43
Microscopic polyangiitis
44
Wegener granulomatosis
269
Pyogenic arthritis
6
C5
💬
6. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Nomacopan
Nomacopan
💬
6. C5
×
Name
Other Names
Nomacopan
Nomacopan (USAN)
Nomacopan
[3]
62
62
,
109
,
162
💬
6. C5
×
Disease ID
Name
62
Paroxysmal nocturnal hemoglobinuria
109
Atypical hemolytic uremic syndrome
162
Pemphigoid
7
C5
💬
7. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Pozelimab
Pozelimab
💬
7. C5
×
Name
Other Names
Pozelimab
Pozelimab (USAN)
Pozelimab
[2]
11
11
,
62
💬
7. C5
×
Disease ID
Name
11
Myasthenia gravis
62
Paroxysmal nocturnal hemoglobinuria
8
C5
💬
8. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Crovalimab
Crovalimab
💬
8. C5
×
Name
Other Names
Crovalimab
Crovalimab (USAN/INN)
Crovalimab (genetical recombination) (JAN)
Crovalimab
[2]
62
62
,
109
💬
8. C5
×
Disease ID
Name
62
Paroxysmal nocturnal hemoglobinuria
109
Atypical hemolytic uremic syndrome
9
C5
💬
9. C5
×
Name
Full Name
C5
complement C5
[11]
Neuroactive ligand-receptor interaction
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extracellular trap formation
,
Regulation of actin cytoskeleton
,
Alcoholic liver disease
,
Prion disease
,
Pertussis
,
Staphylococcus aureus infection
,
Herpes simplex virus 1 infection
,
Coronavirus disease - COVID-19
,
Systemic lupus erythematosus
[11]
Neuroactive ligand-receptor interaction
,
Complement and coagulation cascades
,
Neutrophil extrac
...
Zilucoplan
Zilucoplan
💬
9. C5
×
Name
Other Names
Zilucoplan
Zilucoplan (USAN/INN)
Zilucoplan
[3]
2
2
,
11
,
62
💬
9. C5
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
11
Myasthenia gravis
62
Paroxysmal nocturnal hemoglobinuria
10
CHRM1
💬
10. CHRM1
×
Name
Full Name
CHRM1
cholinergic receptor muscarinic 1
[8]
Calcium signaling pathway
Calcium signaling pathway
,
cAMP signaling pathway
,
Neuroactive ligand-receptor interaction
,
PI3K-Akt signaling pathway
,
Cholinergic synapse
,
Regulation of actin cytoskeleton
,
Alzheimer disease
,
Pathways of neurodegeneration - multiple diseases
[8]
Calcium signaling pathway
,
cAMP signaling pathway
,
Neuroactive ligand-receptor interaction
,
PI3K
...
Atropine
Atropine
💬
10. CHRM1
×
Name
Other Names
Atropine
Atropine (USP)
Atropen (TN)
Atropine
[2]
2
2
,
299
💬
10. CHRM1
×
Disease ID
Name
2
Amyotrophic lateral sclerosis
299
Cystic fibrosis